ロード中...
Treatment of Experimental Cerebral Malaria by Slow Release of Artemisone From Injectable Pasty Formulation
Malaria caused by Plasmodium falciparum causes numerous cases of morbidity with about 400,000 deaths yearly owing, mainly, to inflammation leading to cerebral malaria (CM). CM conventionally is treated by repetitive administration of anti-plasmodial drugs and supportive non-specific drugs, for about...
保存先:
| 出版年: | Front Pharmacol |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7303303/ https://ncbi.nlm.nih.gov/pubmed/32595499 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2020.00846 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|